Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
S Zhong, … , J D Curb, A R Tall
S Zhong, … , J D Curb, A R Tall
Published June 15, 1996
Citation Information: J Clin Invest. 1996;97(12):2917-2923. https://doi.org/10.1172/JCI118751.
View: Text | PDF
Research Article Article has an altmetric score of 11

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

  • Text
  • PDF
Abstract

Plasma high density lipoprotein (HDL) levels are strongly genetically determined and show a general inverse relationship with coronary heart disease (CHD). The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver. A high prevalence of two different CETP gene mutations (D442G, 5.1%; intron 14G:A, 0.5%), was found in 3,469 men of Japanese ancestry in the Honolulu Heart Program and mutations were associated with decreased CETP (-35%) and increased HDL chol levels (+10% for D442G). However, the overall prevalence of definite CHD was 21% in men with mutations and 16% in men without mutations. The relative risk (RR) of CHD was 1.43 in men with mutations (P < .05); after adjustment for CHD risk factors, the RR was 1.55 (P = .02); after additional adjustment for HDL levels, the RR was 1.68 (P = .008). Similar RR values were obtained for the D442G mutation alone. Increased CHD in men with mutations was primarily observed for HDL chol 41-60 mg/dl; for HDL chol > 60 mg/dl men with and without mutations had low CHD prevalence. Thus, genetic CETP deficiency appears to be an independent risk factor for CHD, primarily due to increased CHD prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl. The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i.e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.

Authors

S Zhong, D S Sharp, J S Grove, C Bruce, K Yano, J D Curb, A R Tall

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 1 7 3 5 8 11 6 10 6 21 22 33 12 19 12 23 34 25 20 17 12 22 24 21 25 30 17 28 11 1 1 1 488
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2009 (34)

Title and authors Publication Year
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review
E Boes, S Coassin, B Kollerits, IM Heid, F Kronenberg
Experimental Gerontology 2009
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
M Briel, I Ferreira-Gonzalez, JJ You, PJ Karanicolas, EA Akl, P Wu, B Blechacz, D Bassler, X Wei, A Sharman, I Whitt, SA da Silva, Z Khalid, AJ Nordmann, Q Zhou, SD Walter, N Vale, N Bhatnagar, C O'Regan, EJ Mills, HC Bucher, VM Montori, GH Guyatt
BMJ (Clinical research ed.) 2009
Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice
J Tohyama, JT Billheimer, IV Fuki, GH Rothblat, DJ Rader, JS Millar
Atherosclerosis 2009
The hypertension peril: Lessons from CETP inhibitors
M Hermann, FT Ruschitzka
Current Hypertension Reports 2009
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall
Journal of lipid research 2009
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community
RS Vasan, MJ Pencina, SJ Robins, JP Zachariah, G Kaur, RB D'Agostino, JM Ordovas
Circulation 2009
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study
PN Hopkins, MN Nanjee, LL Wu, MG McGinty, EA Brinton, SC Hunt, JL Anderson
Atherosclerosis 2009
Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
PM Moriarty
Clinical Lipidology 2009
Latest Insights Into High-Density Lipoprotein Functions
H Noto
The Endocrinologist 2009
Association of Two CETP Polymorphisms With HDL Levels in the Chinese Obese Population
X Ruan, L Ma, S Wang, K Lindpaintner, X Liu, B Wang, Z Peng, X Ma, M Cheng, J Zhang, L Liu, X Wang
Obesity 2009
CETP antagonism versus agonism in cardiovascular prevention and plaque regression
CR Sirtori, G Mombelli
Clinical Lipidology 2009
Discovery and Validation of New Molecular Targets in Treating Dyslipidemia: The Role of Human Genetics
AV Khera, DJ Rader
Trends in Cardiovascular Medicine 2009
Frequency and function of CETP variants among individuals of Asian ancestry
JF Thompson, JM Reynolds, SP Williams, LS Wood, SA Paciga, DB Lloyd
Atherosclerosis 2009
The end of the road for CETP inhibitors after torcetrapib?
T Joy, RA Hegele
Current Opinion in Cardiology 2009
Cholesterol Ester Transfer Protein Inhibition: Understanding the Problems
IJ Goldberg
Journal of Cardiovascular Pharmacology 2009
Association of cholesteryl ester transfer protein −629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients
S Tanrikulu, E Ademoglu, F Gurdol, U Mutlu-Turkoglu, AK Bilge, Y Nisanci
Cell Biochemistry and Function 2009
Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice
JV der Weij, S Zadelaar, K Toet, LM Havekes, T Kooistra, PC Rensen
Atherosclerosis 2009
Promoting Mechanisms of Vascular Health
PR Moreno, J Sanz, V Fuster
Journal of the American College of Cardiology 2009
TaqIBpolymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
X Pillois, NP Thi, A Reynaud, D Benchimol, L Lagrost, J Bonnet
Clinical Chemistry and Laboratory Medicine 2009
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
EJ Bighetti, PR Patrício, AC Casquero, JA Berti, HC Oliveira
Lipids in Health and Disease 2009
Lipoproteins, cholesterol homeostasis and cardiac health
TF Daniels, KM Killinger, JJ Michal, RW Wright, Z Jiang
International journal of biological sciences 2009
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma
S Fazio, MR Linton
The Journal of clinical endocrinology and metabolism 2009
Cholesteryl ester transfer protein TaqIB, −629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population
N Padmaja, RM Kumar, J Balachander, C Adithan
Clinica Chimica Acta 2009
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia
F Hermann, F Enseleit, LE Spieker, D Périat, I Sudano, M Hermann, R Corti, G Noll, F Ruschitzka, TF Lüscher
Thrombosis Research 2009
Safety and Tolerability of Dalcetrapib
EA Stein, ES Stroes, G Steiner, BM Buckley, AM Capponi, T Burgess, EJ Niesor, D Kallend, JJ Kastelein
The American Journal of Cardiology 2009
Genomics and Cardiovascular Drug Development
AS Plump, PY Lum
Journal of the American College of Cardiology 2009
The Genetics of High-Density Lipoprotein Metabolism: Clinical Relevance for Therapeutic Approaches
AC Strang, GK Hovingh, ES Stroes, JJ Kastelein
The American Journal of Cardiology 2009
The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors
M Vergeer, ES Stroes
The American Journal of Cardiology 2009
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
L Zhao, W Jin, D Rader, C Packard, G Feuerstein
Biochemical Pharmacology 2009
Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists
M Gurven, H Kaplan, J Winking, DE Rodriguez, S Vasunilashorn, JK Kim, C Finch, E Crimmins, H Harpending
PloS one 2009
Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study
PM Ridker, G Paré, AN Parker, RY Zee, JP Miletich, DI Chasman
Circulation. Cardiovascular genetics 2009
A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load
M Ai, A Tanaka, K Shimokado, R Ohtani, A Inazu, J Kobayashi, H Mabuchi, T Nakano, K Nakajima
Annals of Clinical Biochemistry 2009
Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
TH Johannsen, PR Kamstrup, RV Andersen, GB Jensen, H Sillesen, A Tybjærg-Hansen, BG Nordestgaard
The Journal of clinical endocrinology and metabolism 2009

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Posted by 4 X users
Referenced in 7 Wikipedia pages
Referenced in 1 clinical guideline sources
94 readers on Mendeley
See more details